Progen Pharmaceuticals Limited Launches PharmaSynth Manufacturing Unit Published: Jul 08, 2008 Biotechnology firm ProGen Pharmaceuticals has spun-out its manufacturing operations as the new wholly-owned subsidiary PharmaSynth. Related links press release This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news